3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Prostatic Neoplasms
1
Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Bronchogenic
1
Interventions
Tomography, X-Ray Computed
2
Hematologic Tests
2
Blood Specimen Collection
2
tivozanib
1
pembrolizumab
1
aflibercept
1
Videotape Recording
1
Urination
1
Thoracoscopy
1
Thoracic Surgical Procedures
1
Sulfonylurea Compounds
1
Sodium-Glucose Transporter 2 Inhibitors
1
Referral and Consultation
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Lymph Node Excision
1
Ipilimumab
1
Interviews as Topic
1
Interleukin-15
1
In Situ Hybridization
1
Immunohistochemistry
1
Exercise
1
Erlotinib Hydrochloride
1
Equipment and Supplies
1
Educational Status
1
Dipeptidyl-Peptidase IV Inhibitors
1
Diagnostic Tests, Routine
1
Diagnosis
1
Clinical Laboratory Techniques
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Interleukin-15
×
Thoracic
×
Clear all
NCT07410676
2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2
Recruiting
83 enrolled